Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Ding, Qiang  [Clear All Filters]
2024
Zhang Y, Qiu H, Duan F, An H, Qiao H, Zhang X, Zhang J-R, Ding Q, Na J. A Comparative Study of Human Pluripotent Stem Cell-Derived Macrophages in Modeling Viral Infections. Viruses. 2024;16(4).
2023
Yang B, Liu C, Ju X, Wu B, Wang Z, Dong F, Yu Y, Hou X, Fang M, Gao F, et al. A tissue specific-infection mouse model of SARS-CoV-2. Cell Discov. 2023;9(1):43.
2020
Cao Y, Wu H, Zhai W, Wang Y, Li M, Li M, Yang L, Tian Y, Song Y, Li J, et al. A safety consideration of mesenchymal stem cell therapy on COVID-19. Stem Cell Res. 2020;49:102066.
2016
Maeda K, Ding Q, Yoshimitsu M, Kuwahata T, Miyazaki Y, Tsukasa K, Hayashi T, Shinchi H, Natsugoe S, Takao S. CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells. Int J Mol Sci. 2016;17(7).
2015
Wang XY, Liu CL, Li SD, Xu Y, Chen P, Liu Y, Ding Q, Wahafu W, Hong BF, Yang MH. Hypoxia Precondition Promotes Adipose-Derived Mesenchymal Stem Cells Based Repair of Diabetic Erectile Dysfunction via Augmenting Angiogenesis and Neuroprotection. PLoS One. 2015;10(3):e0118951.
2014
An SMichael, Ding Q, Zhang J, Xie JY, Li LS. Targeting stem cell signaling pathways for drug discovery: advances in the Notch and Wnt pathways. Sci China Life Sci. 2014.
2013
Ding G, Wang L, Xu H, Xu Z, Feng C, Ding Q, Fang Z, Wu Z, Jiang H, Xu J, et al. Mesenchymal stem cells in prostate cancer have higher expressions of SDF-1, CXCR4 and VEGF. Gen Physiol Biophys. 2013.